As a part of its commitment to rare diseases, Sanofi Genzyme focuses on developing therapies for rare genetic disorders that have limited treatment options. This initiative involves research collaborations with patient advocacy groups, clinical trials for rare disease treatments, and raising awareness about these conditions.